Skip to main content

Published locations for Nivolumab benefit for NSCLC persists at 5-year follow-up

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Nivolumab benefit for NSCLC persists at 5-year follow-up

User login

  • Reset your password
  • /content/nivolumab-benefit-nsclc-persists-5-year-follow
  • /oncologypractice/article/211766/lung-cancer/nivolumab-benefit-nsclc-persists-5-year-follow
  • /hematology-oncology/article/211766/lung-cancer/nivolumab-benefit-nsclc-persists-5-year-follow
  • /chestphysician/article/211766/lung-cancer/nivolumab-benefit-nsclc-persists-5-year-follow